FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361292153> ?p ?o ?g. }

• W4361292153 endingPage "453" @default.
• W4361292153 startingPage "453" @default.
• W4361292153 abstract "Anthracycline-containing regimens are highly effective for diffuse large B-cell lymphoma (DLBCL); however, patients with preexisting heart failure (HF) may be less likely to receive anthracyclines and may be at higher risk of lymphoma mortality.To assess the prevalence of preexisting HF in older patients with DLBCL and its association with treatment patterns and outcomes.This longitudinal cohort study used data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare registry from 1999 to 2016. The SEER registry is a system of population-based cancer registries, capturing more than 25% of the US population. Linkage to Medicare offers additional information from billing claims. This study included individuals 65 years and older with newly diagnosed DLBCL from 2000 to 2015 with Medicare Part A or B continuously in the year prior to lymphoma diagnosis. Data were analyzed from September 2020 to December 2022.Preexisting HF in the year prior to DLBCL diagnosis ascertained from billing codes required one of the following: (1) 1 primary inpatient discharge diagnosis, (2) 2 outpatient diagnoses, (3) 3 secondary inpatient discharge diagnoses, (4) 3 emergency department diagnoses, or (5) 2 secondary inpatient discharge diagnoses plus 1 outpatient diagnosis.The primary outcome was anthracycline-based treatment. The secondary outcomes were (1) cardioprotective medications and (2) cause-specific mortality. The associations between preexisting HF and cancer treatment were estimated using multivariable logistic regression. The associations between preexisting HF and cause-specific mortality were evaluated using cause-specific Cox proportional hazards models with adjustment for comorbidities and cancer treatment.Of 30 728 included patients with DLBCL, 15 474 (50.4%) were female, and the mean (SD) age was 77.8 (7.2) years. Preexisting HF at lymphoma diagnosis was present in 4266 patients (13.9%). Patients with preexisting HF were less likely to be treated with an anthracycline (odds ratio, 0.55; 95% CI, 0.49-0.61). Among patients with preexisting HF who received an anthracycline, dexrazoxane or liposomal doxorubicin were used in 78 of 1119 patients (7.0%). One-year lymphoma mortality was 41.8% (95% CI, 40.5-43.2) with preexisting HF and 29.6% (95% CI, 29.0%-30.1%) without preexisting HF. Preexisting HF was associated with higher lymphoma mortality in models adjusting for baseline and time-varying treatment factors (hazard ratio, 1.24; 95% CI, 1.18-1.31).In this study, preexisting HF in patients with newly diagnosed DLBCL was common and was associated with lower use of anthracyclines and lower use of any chemotherapy. Trials are needed for this high-risk population." @default.
• W4361292153 created "2023-03-31" @default.
• W4361292153 creator A5000172588 @default.
• W4361292153 creator A5006559598 @default.
• W4361292153 creator A5014933224 @default.
• W4361292153 creator A5015102832 @default.
• W4361292153 creator A5017116248 @default.
• W4361292153 creator A5038526399 @default.
• W4361292153 creator A5047509474 @default.
• W4361292153 creator A5051961415 @default.
• W4361292153 creator A5061952939 @default.
• W4361292153 creator A5062249687 @default.
• W4361292153 creator A5082036540 @default.
• W4361292153 creator A5083026024 @default.
• W4361292153 creator A5084265906 @default.
• W4361292153 date "2023-05-01" @default.
• W4361292153 modified "2023-10-14" @default.
• W4361292153 title "Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma" @default.
• W4361292153 cites W1833330468 @default.
• W4361292153 cites W1957304651 @default.
• W4361292153 cites W1974451585 @default.
• W4361292153 cites W2028311823 @default.
• W4361292153 cites W2059796825 @default.
• W4361292153 cites W2096593771 @default.
• W4361292153 cites W2109775164 @default.
• W4361292153 cites W2111350156 @default.
• W4361292153 cites W2112196039 @default.
• W4361292153 cites W2131424155 @default.
• W4361292153 cites W2140182328 @default.
• W4361292153 cites W2147646179 @default.
• W4361292153 cites W2152124377 @default.
• W4361292153 cites W2154746519 @default.
• W4361292153 cites W2178975869 @default.
• W4361292153 cites W2260466831 @default.
• W4361292153 cites W2324528766 @default.
• W4361292153 cites W2591402457 @default.
• W4361292153 cites W2697497789 @default.
• W4361292153 cites W2756103188 @default.
• W4361292153 cites W2799900329 @default.
• W4361292153 cites W2911752236 @default.
• W4361292153 cites W2912139642 @default.
• W4361292153 cites W2942798572 @default.
• W4361292153 cites W2976106895 @default.
• W4361292153 cites W2984766121 @default.
• W4361292153 cites W3029431699 @default.
• W4361292153 cites W3133685805 @default.
• W4361292153 cites W3190445364 @default.
• W4361292153 cites W3204395813 @default.
• W4361292153 cites W4200452381 @default.
• W4361292153 cites W4210242902 @default.
• W4361292153 cites W4220962018 @default.
• W4361292153 cites W4221098374 @default.
• W4361292153 cites W4225302703 @default.
• W4361292153 cites W4226237761 @default.
• W4361292153 cites W4231179998 @default.
• W4361292153 cites W4245386327 @default.
• W4361292153 cites W4245604276 @default.
• W4361292153 cites W4249999102 @default.
• W4361292153 doi "https://doi.org/10.1001/jamacardio.2023.0303" @default.
• W4361292153 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36988926" @default.
• W4361292153 hasPublicationYear "2023" @default.
• W4361292153 type Work @default.
• W4361292153 citedByCount "3" @default.
• W4361292153 countsByYear W43612921532023 @default.
• W4361292153 crossrefType "journal-article" @default.
• W4361292153 hasAuthorship W4361292153A5000172588 @default.
• W4361292153 hasAuthorship W4361292153A5006559598 @default.
• W4361292153 hasAuthorship W4361292153A5014933224 @default.
• W4361292153 hasAuthorship W4361292153A5015102832 @default.
• W4361292153 hasAuthorship W4361292153A5017116248 @default.
• W4361292153 hasAuthorship W4361292153A5038526399 @default.
• W4361292153 hasAuthorship W4361292153A5047509474 @default.
• W4361292153 hasAuthorship W4361292153A5051961415 @default.
• W4361292153 hasAuthorship W4361292153A5061952939 @default.
• W4361292153 hasAuthorship W4361292153A5062249687 @default.
• W4361292153 hasAuthorship W4361292153A5082036540 @default.
• W4361292153 hasAuthorship W4361292153A5083026024 @default.
• W4361292153 hasAuthorship W4361292153A5084265906 @default.
• W4361292153 hasConcept C107130276 @default.
• W4361292153 hasConcept C121608353 @default.
• W4361292153 hasConcept C126322002 @default.
• W4361292153 hasConcept C142724271 @default.
• W4361292153 hasConcept C194828623 @default.
• W4361292153 hasConcept C2776802502 @default.
• W4361292153 hasConcept C2778527826 @default.
• W4361292153 hasConcept C2778559949 @default.
• W4361292153 hasConcept C2779338263 @default.
• W4361292153 hasConcept C2908647359 @default.
• W4361292153 hasConcept C45827449 @default.
• W4361292153 hasConcept C50382708 @default.
• W4361292153 hasConcept C530470458 @default.
• W4361292153 hasConcept C534262118 @default.
• W4361292153 hasConcept C71924100 @default.
• W4361292153 hasConcept C99454951 @default.
• W4361292153 hasConceptScore W4361292153C107130276 @default.
• W4361292153 hasConceptScore W4361292153C121608353 @default.
• W4361292153 hasConceptScore W4361292153C126322002 @default.
• W4361292153 hasConceptScore W4361292153C142724271 @default.

• next